Diversa specializes in advanced drug delivery solutions using patented lipid nanoparticles technology, aimed at improving bioavailability and targeting of therapeutics. Our focus areas include enhancing delivery for poorly soluble drugs, RNA therapies, gene editing, and protein-based treatments. Ideal for pharmaceutical and biotech companies seeking efficient formulation and intracellular delivery, our platform offers significant advantages for oncology, rare diseases, and personalized medicine. We also extend our innovative solutions to dermocosmetics and nutraceuticals, providing versatile, scalable, and safe delivery systems.
Key partnership opportunities lie with entities in drug development, therapeutic innovation, and academic research, looking to overcome delivery challenges in clinical trials. Our technology is particularly beneficial for companies focusing on bioavailability, targeted delivery, solubility improvement, and safety profiles of active ingredients.
DIVERSA Technologies offers custom formulation services based on proprietary lipid nanoparticles and nanoemulsion-based delivery systems for challenging molecules.
DIVERSA Technologies is launching Sphirence, a cosmetic and nutraceutical technology platform based on advanced emulsion systems designed to enhance the performance of active ingredients.
SPHIRO™ is a next-generation active delivery ingredient developed by DIVERSA Technologies, combining biomimetic lipids and antioxidant actives in a unique particulate architecture designed to enhance skin performance.